BOUDA MEDIC
ActiveBOUDA MEDIC has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €37k and a net result of €148k. Equity remains stable across the filed fiscal years (±1.9% per year). Its solvency ranks better than 16% of 16527 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
72
/ 100
Healthy
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency39▼-35
Growth58▼-20
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2.5k at 30 days acceptable
Liquidity tight (current ratio 1.13 against 1.94 in 2024; short-term debt: 86% and cash: 79.4% of total assets), and 86.3% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Eight signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
13.7%
Return on assets
54.2%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 16% of 16527 sector peers (2025).
NBB · sector comparisonPosition among 16527 sector peers
Solvency
better than 16%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-04-2026, 95 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
95 d early
2024
19 d late
2023
13 d late
2022
7 d late
2021
52 d late
2020
20 d late
2019
4 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
22-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€37k▼ 52.2%
2024 · €78k
2018: €42k
2019: €65k
2020: €59k
2021: €82k
2022: €78k
2023: €78k
2024: €78k
2018 → 2025
Total assets
€274k▲ 70.4%
2024 · €161k
2018: €101k
2019: €113k
2020: €78k
2021: €92k
2022: €106k
2023: €144k
2024: €161k
2018 → 2025
Net result
€148k▲ 70.7%
2024 · €87k
2018: €47k
2019: €37k
2020: €-6k
2021: €17k
2022: €-4k
2023: €40k
2024: €87k
2018 → 2025
Working capital
€30k▼ 59.5%
2024 · €73k
2018: €-27k
2019: €19k
2020: €29k
2021: €67k
2022: €73k
2023: €74k
2024: €73k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€82k-€78k▼ 4.7%€78k=€78k=€37k▼ 52.2%
Operating result€25k-€-1k€53k€120k▲ 124%€202k▲ 68.7%
Net result€17k-€-4k€40k€87k▲ 119%€148k▲ 70.7%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed three years in a row; 2025 is 69% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €274k
Fixed assets
€9k▼ 13.0%
Current assets
€265k▲ 76.0%
Equity and liabilities €274k
Equity
€37k▼ 52.2%
Debt
€236k▲ 187%
The debt ratio rises from 51.2% to 86.3%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€207k▲
2024 · €124k
Cash flow
€153k▲
2024 · €92k
Solvency
13.7%▼
2024 · 48.8%
Current ratio
1.13▼
2024 · 1.94
Quick ratio
1.13▼
2024 · 1.94
Debt / equity
6.31▲
2024 · 1.05
ROE
396.0%▲
2024 · 110.8%
ROA
54.2%▲
2024 · 54.1%
Interest coverage
391.31▼
2024 · 496.10
Debt
€236k▲
2024 · €82k
Debt ≤ 1 year
€236k▲
2024 · €78k
Debt > 1 year
€969▼
2024 · €5k
Income taxes
€53k▲
2024 · €33k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€161k€274k▲
Fixed assets21/28€10k€9k▼
Tangible fixed assets22/27€10k€9k▼
Furniture and vehicles24€10k€9k▼
Current assets29/58€151k€265k▲
Amounts receivable within one year40/41€30k€47k▲
Trade receivables40€27k€44k▲
Other amounts receivable41€2k€3k▲
Cash at bank and in hand54/58€121k€218k▲
Equity and liabilities
Total equity and liabilities10/49€161k€274k▲
Equity10/15€78k€37k▼
Contributions10/11€19k€19k=
Reserves13€19k€19k=
Distributable reserves133€19k€19k=
Profit (loss) carried forward14€41k-
Amounts payable17/49€82k€236k▲
Amounts payable after more than one year17€5k€969▼
Financial debts170/4€5k€969▼
Amounts payable within one year42/48€78k€236k▲
Current portion of amounts payable after more than one year42€8k€12k▲
Trade debts44€2k€3k▲
Suppliers440/4€2k€3k▲
Taxes, remuneration and social security45€34k€60k▲
Taxes450/3€34k€60k▲
Other amounts payable47/48€35k€161k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€5k€5k▲
Other operating charges640/8€3k€4k▲
Gross operating margin9900€127k€210k▲
Operating profit (loss)9901€120k€202k▲
Financial income75/76B€348€702▲
Recurring financial income75€348€702▲
Financial charges65/66B€251€528▲
Recurring financial charges65€251€528▲
Profit (loss) for the period before taxes9903€120k€202k▲
Income taxes67/77€33k€53k▲
Profit (loss) for the period9904€87k€148k▲
Profit (loss) for the period to be appropriated9905€87k€148k▲
Appropriation of the result
Profit (loss) to be appropriated9906€128k€189k▲
Profit (loss) brought forward from the previous period14P€41k€41k=
Profit to be distributed694/7€87k€189k▲
Return on contributions (dividend)694€87k€189k▲
The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
27-04
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2018net €148k ▲70.7%
Operating result €202k, net result €148k, both a record.
19-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 19 days late
2024
13-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 13 days late
2023
31-12
Financial
Back to profitnet €40k
Net result €40k after one loss-making year.
07-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 7 days late
2022
21-09
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 52 days late
2021
31-12
Financial
Back to profitnet €17k
Net result €17k after one loss-making year.
31-12
Financial
Liquidity triplescurrent ratio 7.89
Current ratio from 2.51 to 7.89; short-term debt falls from €19k to €10k.
20-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 20 days late
2020
31-12
Financial
Weakest financial yearnet €-6k ▼116%
Net result drops to €-6k, the lowest in the series; recovery starts the following year.
27-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
31-12
Financial
Liquidity triplescurrent ratio 1.40
Current ratio from 0.52 to 1.40; short-term debt falls from €56k to €48k.
30-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 30 days late
2018
30-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 30 days late
2017
31-08
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Rixensart · 1 establishment unit since 2015
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Avenue de Montalembert 32/A1330 RixensartGround area
109 m²
Building footprint
82 m²
Volume, LiDAR
690 m³
Parcel 25091C0182/00_000, Wallonia · tallest building 10.3 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
BOUDA MEDIC
since 20152.240.663.772
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25091C0182/00_000 | Wallonia | 109 m² | 1 · 82 m² | 10.3 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dacy Médi Care
BE 1005.046.791
Sint-Lambrechts-Woluwe · Eq €37k
Dr. Grace Gan
BE 1014.432.730
Kasterlee · Eq €37k
Huisarts Dr. Leonie Vandoorne
BE 0770.723.693
Avelgem · Eq €37k
DR.KHALID KHAN, HUISARTS
BE 0761.627.073
Gent · Eq €38k
BEN YAHYATEN
BE 0568.940.038
Sint-Agatha-Berchem · Eq €37k
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 4,184 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded06-03-2015
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 11 filingsAddress and cadastre registers
Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.